Extrait

The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and minimum pharmacologically active dose of peginesatide in Healthy Volunteers.

Critère d'inclusion

• Anemia ,chronic kidney disease ,Chronic renal failure ,Cancer

Liens

• nct
• ictrp